• Home
  • Politics
  • News
  • Business
  • Health
  • Entertainment
  • Sports
  • Lifestyle
  • Education
  • Opinion
Monday, 15 August, 2022
  • Login
topfmonline.com
 
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Sports
  • Education
  • Technology
  • Foreign
No Result
View All Result
topfmonline.com
No Result
View All Result
Home Foreign

BioMarin drug becomes first U.S. approved therapy for dwarfism

TOPFM NEWS by TOPFM NEWS
November 22, 2021
in Foreign
A A
0
BioMarin drug becomes first U.S. approved therapy for dwarfism
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

The first medication for children with the most common type of dwarfism has been approved in the U.S.

The BioMarin Pharmaceutical Inc’s (BMRN.O) once-daily injection received clearance from the U.S. health regulator making it the first approved therapy for achondroplasia in the country.

The approval for Voxzogo, intended for children aged five and older, comes months after it became the first therapy to be greenlighted by regulators for the treatment of the genetic condition in Europe.

Many countries still do not have an approved therapy for Achondroplasia, a condition characterized by short stature which occurs in about one in every 25,000 newborns worldwide.

BioMarin expects the therapy’s annual net revenue per patient in the United States to be about $240,000 and expects about 3,000 children with achondroplasia in the country to be eligible for the treatment.

Voxzogo is expected to be available in the United States by mid-to-late December at a list price of $899 per vial, the company said.

BioMarin’s late-stage Voxzogo study showed improvements in patients’ growth rate over a year and was well tolerated. The drug is also being studied in children below five years and has already been approved in Europe for those aged two and above.

The U.S. Food and Drug Administration had in April extended the review of the drug by three months to assess two-year data on the drug.

It has now cleared the drug under the accelerated approval pathway, which requires a post-marketing study assessing final adult height.

BioMarin said it intended to use the results from ongoing extension studies to receive final approval.

The drug is also under regulatory review in Japan, Brazil, and Australia and could receive approval in the countries next year, BioMarin said.

Source: Reuters

Related Posts

Ukraine war crimes investigation receives support of 45 nations

Ukraine war crimes investigation receives support of 45 nations

July 15, 2022
3
Ivana Trump, former US president’s first wife, dies aged 73

Ivana Trump, former US president’s first wife, dies aged 73

July 15, 2022
1
Previous Post

GIJ replies Bridget Otoo; ‘Be proud of GIJ’

Next Post

Remember You Told Us Taxation Was a Lazy Man’s Approach! – Chief Biney To President Akufo-Addo

Related Posts

Ukraine war crimes investigation receives support of 45 nations
Foreign

Ukraine war crimes investigation receives support of 45 nations

July 15, 2022
3
Ivana Trump, former US president’s first wife, dies aged 73
Foreign

Ivana Trump, former US president’s first wife, dies aged 73

July 15, 2022
1
Russia, Ukraine near to grain deal as heavy shelling continues
Foreign

Russia, Ukraine near to grain deal as heavy shelling continues

July 14, 2022
1
US, Israel to commit to stopping Iran nuclear ambitions
Foreign

US, Israel to commit to stopping Iran nuclear ambitions

July 14, 2022
1
US health officials urge booster shots as COVID variants spread
Foreign

US health officials urge booster shots as COVID variants spread

July 13, 2022
1
Ukraine to get $1.7bn in new aid to pay healthcare workers
Foreign

Ukraine to get $1.7bn in new aid to pay healthcare workers

July 13, 2022
3
Next Post
Remember You Told Us Taxation Was a Lazy Man’s Approach! – Chief Biney To President Akufo-Addo

Remember You Told Us Taxation Was a Lazy Man's Approach! - Chief Biney To President Akufo-Addo

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Business
  • Education
  • Entertainment
  • Foreign
  • Health
  • Lifestyle
  • News
  • Opinion
  • Politics
  • Sports
  • Technology
  • Uncategorized

BROWSE BY TOPICS

5G 2022 Budget AFCON Afghanistan akufo addo Amazon Apiate explosion Appiate apple AT&T Biden Black Stars covid COVID-19 COVID 19 E-Levy facebook Ghana Police Service Google health Intel iphone manchester united meta Microsoft NLC Nvidia OMICRON OnePlus 10 Pro Parliament police Qualcomm Russia South Africa Taliban tech TESCON Tesla twitter US UTAG vaccine Verizon WHO Xinjiang

Recent Posts

  • We’re doing as much as we can to revive Ghana’s economy – IMF 
  • Selected KNUST students to get funding to develop problem-solving modules 
  • TikTok launches an elections hub in Kenya ahead of General Elections
  • Facebook to allow up to five profiles tied to one account
  • Ukraine war crimes investigation receives support of 45 nations

Recent Comments

No comments to show.

RECENT NEWS

  • We’re doing as much as we can to revive Ghana’s economy – IMF  July 15, 2022
  • Selected KNUST students to get funding to develop problem-solving modules  July 15, 2022
  • TikTok launches an elections hub in Kenya ahead of General Elections July 15, 2022
  • Facebook to allow up to five profiles tied to one account July 15, 2022

MAIN CATEGORIES

  • Business
  • Education
  • Entertainment
  • Foreign
  • Health
  • Lifestyle
  • News
  • Opinion
  • Politics
  • Sports
  • Technology
  • Uncategorized

Entertainment

TOP FM enters Mallam Atta market with “Apomuden” Festival
Business

TOP FM enters Mallam Atta market with “Apomuden” Festival

5 months ago
6
  • ABOUT US
  • CONTACT
  • ADVERTISE

© 2022 Top Media Group - Powered by BackUp Data Systems

No Result
View All Result
  • Home
  • Politics
  • News
  • Business
  • Health
  • Entertainment
  • Sports
  • Lifestyle
  • Education
  • Opinion

© 2022 Top Media Group - Powered by BackUp Data Systems

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In